128 related articles for article (PubMed ID: 8374878)
1. Localized renal cell carcinoma treated by radical nephrectomy. Influence of pathologic data and the importance of DNA ploidy pattern on disease outcome.
Raviv G; Leibovich I; Mor Y; Nass D; Medalia O; Goldwasser B; Nativ O
Cancer; 1993 Oct; 72(7):2207-12. PubMed ID: 8374878
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
Currin SM; Lee SE; Walther PJ
J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
4. Surgical enucleation for renal cell carcinoma (RCC). Prognostic significance of tumour stage, grade and DNA ploidy.
Di Silverio F; Sciarra A; Flammia GP; Mariani M; De Vico A; Buscarini M
Scand J Urol Nephrol; 1997 Apr; 31(2):123-8. PubMed ID: 9165573
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors for disease progression in patients with renal cell carcinoma].
Budía Alba A; Gómez Pérez L; Bango V; Ruiz-Cerdá JI; Sempere A; Queipo JA; Jiménez Cruz JF
Actas Urol Esp; 2007 Sep; 31(8):831-44. PubMed ID: 18020207
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
Ljungberg B; Larsson P; Stenling R; Roos G
J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma in young and old patients. Comparison of prognostic pathologic variables (cell type, tumor grade and stage, and DNA ploidy pattern) and their impact on disease outcome.
Rainwater LM; Zincke H; Farrow GM; Gonchoroff NJ
Urology; 1991 Jul; 38(1):1-5. PubMed ID: 1866850
[TBL] [Abstract][Full Text] [Related]
11. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma.
Di Silverio F; Casale P; Colella D; Andrea L; Seccareccia F; Sciarra A
Cancer; 2000 Feb; 88(4):835-43. PubMed ID: 10679653
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of DNA ploidy in small renal cell carcinoma.
Shalev M; Gdor Y; Leventis A; Radnay J; Shapiro H; Bernheim J; Nissenkorn I
Pathol Res Pract; 2001; 197(1):7-12. PubMed ID: 11209819
[TBL] [Abstract][Full Text] [Related]
13. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
15. Prognostic score for patients with localized renal cell carcinoma treated by nephrectomy.
Nativ O; Sabo E; Madeb R; Halachmi S; Madjar S; Moskovitz B
Isr Med Assoc J; 2001 Jan; 3(1):24-7. PubMed ID: 11344796
[TBL] [Abstract][Full Text] [Related]
16. Cytofluorometric and cytogenetic evaluation of renal cell carcinoma: correlations with the clinical course.
Bartoletti R; Selli C; Nicolò G; Margallo E; Amorosi A
Urol Int; 1997; 58(1):1-7. PubMed ID: 9058512
[TBL] [Abstract][Full Text] [Related]
17. The impact of tumor size on clinical outcome in patients with localized renal cell carcinoma treated by radical nephrectomy.
Nativ O; Sabo E; Raviv G; Madjar S; Halachmi S; Moskovitz B
J Urol; 1997 Sep; 158(3 Pt 1):729-32. PubMed ID: 9258069
[TBL] [Abstract][Full Text] [Related]
18. [Flow cytometric DNA analysis on renal cell carcinoma--a study of 116 cases on fresh surgical specimens].
Nakazawa H; Ito F; Okuda H; Ryoji O; Kihara T; Goya N; Takahashi K; Toma H
Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):242-50. PubMed ID: 8121106
[TBL] [Abstract][Full Text] [Related]
19. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
[TBL] [Abstract][Full Text] [Related]
20. Flow-cytometric DNA analysis of paraffin-embedded renal cell carcinoma tissue from patients treated by parenchymal-sparing surgery.
Ciancio G; Ferrell S; Block NL
Br J Urol; 1995 Nov; 76(5):570-4. PubMed ID: 8535674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
